2-Fluoro-4-iodobenzonitrile

We are 2-Fluoro-4-iodobenzonitrile CAS:137553-42-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Fluoro-4-iodobenzonitrile
CAS.NO:137553-42-5
Synonyms:2-Fluoro-4-iodobenzonitrile
 
Physical and Chemical Properties:
Density 2.0±0.1 g/cm3
Boiling Point 264.0±25.0 °C at 760 mmHg
Melting Point 103.7-104.6ºC
Molecular Formula C7H3FIN
Molecular Weight 247.008
Flash Point 113.4±23.2 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.630
 
Specification:
Appearance:Off-white to light yellow powder
Assay:≥98.0%
Loss on drying:≤0.3%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

2-Fluoro-4-iodobenzonitrile


Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?3,5-di-(tert-butyl-dimethylsilyloxy)-(3S,5S)-cyclohexan-1-one This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?915095-87-3 Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.4,4-Dimethyl-1,2-oxazolidin-3-one CAS:81778-07-6 Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.

Related Products
Product Name
2-Chloro-3-fluoro-5-methylpyridine View Details
3,4-Dichloro-2-fluoroaniline View Details
2-Chloropropane View Details
triethoxy(propyl)silane manufacturer Rhodanine-3-acetic acid manufacturer 3-Nitrophthalic acid manufacturer 6-Carboxy-4-methyl-2-propylbenzimidazole manufacturer [2-(methylamino)pyridin-3-yl]methanol manufacturer